Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Takeda Pharmaceutical Company Limited    4502   JP3463000004

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 4 098 2667 029 1615 153 3645 586 525--
Entreprise Value (EV)1 4 708 76012 054 7439 609 0549 521 3098 831 4898 288 337
P/E ratio 21,7x40,0x118x42,5x13,1x11,3x
Yield 3,47%3,98%5,44%5,04%5,04%5,04%
Capitalization / Revenue 2,31x3,35x1,57x1,71x1,67x1,64x
EV / Revenue 2,66x5,75x2,92x2,91x2,64x2,44x
EV / EBITDA 10,8x25,3x14,0x8,48x7,07x6,39x
Price to Book 2,03x1,36x1,09x1,20x1,17x1,12x
Nbr of stocks (in thousands) 790 7131 554 7801 557 8491 563 102--
Reference price (JPY) 5 1834 5213 3083 5743 5743 574
Last update 05/14/201805/14/201905/13/202009/23/202009/23/202009/23/2020
1 JPY in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 1 770 5312 097 2003 291 2003 267 1663 341 5613 398 400
EBITDA1 437 460477 415684 0571 122 5801 249 1981 296 965
Operating profit (EBIT)1 241 789205 000100 400431 947646 410732 872
Operating Margin 13,7%9,77%3,05%13,2%19,3%21,6%
Pre-Tax Profit (EBT)1 217 20594 896-60 754281 839583 570658 322
Net income1 186 886109 10044 200177 147399 437459 283
Net margin 10,6%5,20%1,34%5,42%12,0%13,5%
EPS2 23911328,084,1272317
Dividend per Share2 180180180180180180
Last update 05/14/201805/14/201905/13/202008/27/202008/27/202006/23/2020
1 JPY in Million
2 JPY
Estimates
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 610 4945 025 5824 455 6903 934 7843 244 9642 701 811
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,40x10,5x6,51x3,51x2,60x2,08x
Free Cash Flow1 471 196-2 507 219961 871754 498900 366934 524
ROE (Net Profit / Equities) 9,60%3,00%0,90%3,09%9,90%9,73%
Shareholders' equity1 1 946 7293 636 6674 911 1115 741 7824 036 3464 721 664
ROA (Net Profit / Asset) 5,13%1,06%-0,46%1,23%3,99%3,40%
Assets1 3 640 51110 334 963-9 710 01814 460 99510 010 94613 508 320
Book Value Per Share2 2 5573 3193 0322 9753 0483 183
Cash Flow per Share2 490397403514584581
Capex1 67 00577 677127 082176 298183 286178 375
Capex / Sales 3,78%3,70%3,86%5,40%5,49%5,25%
Last update 05/14/201805/14/201905/13/202010/08/202010/08/202010/08/2020
1 JPY in Million
2 JPY
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (JPY)
5 586 525 207 750
Capitalization (USD)
52 973 432 403
Net sales (JPY)
3 291 200 000 000
Net sales (USD)
31 167 664 000
Number of employees
47 495
Sales / Employee (JPY)
69 295 715
Sales / Employee (USD)
656 230
Free-Float
99,1%
Free-Float capitalization (JPY)
5 533 619 291 898
Free-Float capitalization (USD)
52 471 759 564
Avg. Exchange 20 sessions (JPY)
16 552 434 178
Avg. Exchange 20 sessions (USD)
156 751 552
Average Daily Capital Traded
0,3%
EPS & Dividend